FIELD: medicine.
SUBSTANCE: individually chosen low-calorie diet, 6.21 mg spirapril daily, and 300 mg tablet allicor twice a day, are administered.
EFFECT: thrombocyte function normalisation, significantly decreasing risk of thrombosis complications in metabolic syndrome.
1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| TREATMENT METHOD FOR PRIMARY HEMOSTASIA DISORDERS IN METABOLIC SYNDROME PATIENTS | 2007 |
|
RU2342137C2 |
| METHOD FOR OPTIMISATION OF THROMBOCYTE FUNCTIONS IN METABOLIC SYNDROME PATIENTS | 2007 |
|
RU2339380C1 |
| METHOD OF FUNCTIONAL ABILITY NORMALISATION | 2007 |
|
RU2342128C1 |
| METHOD FOR THROMBOCYTE DISORDERS CORRECTION IN METABOLIC SYNDROME | 2007 |
|
RU2342136C2 |
| METHOD OF DECREASE OF BLOOD PLATES ACTIVITY AT METHABOLIC SYNDROME | 2007 |
|
RU2337683C1 |
| TREATMENT METHOD FOR PLATELET DYSFUNCTION IN METABOLIC SYNDROME PATIENTS | 2007 |
|
RU2342134C1 |
| METHOD OF LEVELLING OF DYSFUNCTIONS OF THROMBOCYTES IN CONDITIONS OF METABOLIC SYNDROME | 2007 |
|
RU2343916C1 |
| METHOD FOR NORMALIZING THROMBOCYTIC DISORDERS IN CASE OF METABOLIC SYNDROME | 2004 |
|
RU2268046C1 |
| METHOD OF DECREASED THROMBOCYTE ACTIVITY IN PATIENTS SUFFERING FROM METABOLIC SYNDROME | 2007 |
|
RU2345764C2 |
| METHOD FOR CORRECTING THROMBOCYTIC DYSFUNCTIONS IN CASE OF METABOLIC SYNDROME | 2004 |
|
RU2268041C1 |
